Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Effect of LINGO-1 gene silencing on movement function of EAE mice].
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
Microglia in central nervous system repair after injury.
Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy.
Your client has multiple sclerosis: understanding the challenge.
Neurogenic detrusor overactivity: an update on management options.
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D3-Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Concise review: Stem cell trials using companion animal disease models.
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Acute disseminated encephalomyelitis following biting by a scolopendra subspinipes mutilans.
Pages
« first
‹ previous
…
488
489
490
491
492
493
494
495
496
…
next ›
last »